Compare ENTA & YDDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | YDDL |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | Philippines |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.7M | 358.9M |
| IPO Year | 2012 | N/A |
| Metric | ENTA | YDDL |
|---|---|---|
| Price | $13.71 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.40 | N/A |
| AVG Volume (30 Days) | ★ 245.3K | 21.3K |
| Earning Date | 05-11-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,814,000.00 | N/A |
| Revenue This Year | $7.76 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $40.85 |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $6.44 | $1.95 |
| 52 Week High | $17.15 | $16.23 |
| Indicator | ENTA | YDDL |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 27.71 |
| Support Level | $13.19 | N/A |
| Resistance Level | $13.97 | $3.03 |
| Average True Range (ATR) | 0.80 | 0.21 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 30.12 | 10.45 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.